BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31987805)

  • 1. Differentiation between benign and malignant ovarian masses using multiparametric MRI.
    Türkoğlu S; Kayan M
    Diagn Interv Imaging; 2020 Mar; 101(3):147-155. PubMed ID: 31987805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
    Lee SK; Jee WH; Jung CK; Chung YG
    Br J Radiol; 2020 Nov; 93(1115):20191035. PubMed ID: 32649224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of orbital masses by multiparametric MRI.
    Ro SR; Asbach P; Siebert E; Bertelmann E; Hamm B; Erb-Eigner K
    Eur J Radiol; 2016 Feb; 85(2):324-36. PubMed ID: 26781137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
    Xu X; Wang P; Ma L; Shao Z; Zhang M
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI.
    Malek M; Pourashraf M; Mousavi AS; Rahmani M; Ahmadinejad N; Alipour A; Hashemi FS; Shakiba M
    Asian Pac J Cancer Prev; 2015; 16(8):3407-12. PubMed ID: 25921153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E; Yoon YC; Kim JH; Kim K
    Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
    Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
    Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
    Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
    J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of quantitative multiparametric MRI in differentiating pleomorphic adenomas from malignant epithelial tumors in lacrimal gland.
    Wang Y; Song L; Guo J; Xian J
    Neuroradiology; 2020 Sep; 62(9):1141-1147. PubMed ID: 32430642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
    Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of Benign From Malignant Sinonasal Masses Using Diffusion Weighted Imaging and Dynamic Contrast Enhanced Magnetic Resonance Imaging.
    Daga R; Kumar J; Pradhan G; Meher R; Malhotra V; Khurana N
    Am J Rhinol Allergy; 2022 Mar; 36(2):207-215. PubMed ID: 34486401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multiparametric analysis based on DCE-MRI to improve the accuracy of parotid tumor discrimination.
    Xu Z; Zheng S; Pan A; Cheng X; Gao M
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2228-2234. PubMed ID: 31372671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of dynamic contrast-enhanced MRI in the differentiation between benign and malignant lacrimal epithelial tumors].
    Wang YZ; Xian JF; Wang XY; Guo J; Song LY
    Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(31):2427-2432. PubMed ID: 37599217
    [No Abstract]   [Full Text] [Related]  

  • 19. Diffusion MRI of uterine and ovarian masses: identifying the benign lesions.
    Davarpanah AH; Kambadakone A; Holalkere NS; Guimaraes AR; Hahn PF; Lee SI
    Abdom Radiol (NY); 2016 Dec; 41(12):2466-2475. PubMed ID: 27660280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
    Park S; Park JG; Jun S; Kim H; Kim TS; Kang H
    Magn Reson Imaging; 2020 Nov; 73():118-124. PubMed ID: 32860869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.